|
TTC31 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.865980E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.941600E-02 |
| Normal-vs-Stage2 |
1.378010E-02 |
| Normal-vs-Stage3 |
4.180600E-03 |
| Normal-vs-Stage4 |
9.975800E-02 |
| Stage1-vs-Stage2 |
2.043600E-01 |
| Stage1-vs-Stage3 |
1.092960E-01 |
| Stage1-vs-Stage4 |
7.510600E-01 |
| Stage2-vs-Stage3 |
9.235600E-01 |
| Stage2-vs-Stage4 |
4.695600E-01 |
| Stage3-vs-Stage4 |
4.262400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.896800E-03 |
| Normal-vs-AfricanAmerican |
5.429000E-01 |
| Normal-vs-Asian |
4.616000E-01 |
| Caucasian-vs-AfricanAmerican |
2.340000E-01 |
| Caucasian-vs-Asian |
7.361600E-04 |
| AfricanAmerican-vs-Asian |
2.852000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.274200E-02 |
| Normal-vs-Female |
1.342080E-02 |
| Male-vs-Female |
7.186200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.741800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.512100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.239700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.423670E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.507600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.506200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.740790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.917200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.433800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.835800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.418100E-02 |
| Classical-VS-Follicular |
6.872500E-02 |
| Classical-VS-Other |
8.890400E-01 |
| Classical-VS-Normal |
9.528000E-02 |
| Tall-VS-Follicular |
7.076600E-01 |
| Tall-VS-Other |
5.208600E-01 |
| Tall-VS-Normal |
3.336400E-03 |
| Follicular-VS-Other |
5.221200E-01 |
| Follicular-VS-Normal |
1.235720E-02 |
| Other-VS-Normal |
6.096800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.446000E-02 |
| Normal-vs-N1 |
1.810620E-01 |
| N0-vs-N1 |
6.081400E-01 |
|
|
